title: Successful treatment of FKBP51-expressed multicentric reticulohistiocytosis using combination therapy with low-dose denosumab and tacrolimus.
authors.affiliation: a Department of Rheumatology , Hiroshima City Hiroshima Citizens Hospital , Hiroshima , Japan.
authors.forename: S
authors.initials: S
authors.lastname: Mokuda
authors.affiliation: a Department of Rheumatology , Hiroshima City Hiroshima Citizens Hospital , Hiroshima , Japan.
authors.forename: H
authors.initials: H
authors.lastname: Oiwa
mesh_terms: D000328:Adult; D001168:Arthritis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D000069448:Denosumab / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D050823:Hand Joints / Q000000981:diagnostic imaging / Q000473:pathology*; D015616:Histiocytosis, Non-Langerhans-Cell / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D011859:Radiography; D016559:Tacrolimus / Q000627:therapeutic use*; D022021:Tacrolimus Binding Proteins / Q000378:metabolism; D000099159:Tacrolimus Binding Protein 5
chemical_list: D050071:Bone Density Conservation Agents; D000069448:Denosumab; D007166:Immunosuppressive Agents; D016559:Tacrolimus; D022021:Tacrolimus Binding Proteins; D000099159:Tacrolimus Binding Protein 5